Issue 4/2019
Content (33 Articles)
Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
Jan Brož, Denisa Janíčková Ždárská, Jana Urbanová
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
Sarita Bajaj, A. K. Das, Sanjay Kalra, Rakesh Sahay, Banshi Saboo, Sambit Das, M. Shunmugavelu, Jubbin Jacob, Gagan Priya, Deepak Khandelwal, Deep Dutta, Manoj Chawla, Vineet Surana, Mangesh Tiwaskar, Ameya Joshi, Pradip Krishna Shrestha, Jyoti Bhattarai, Bishwajit Bhowmik, Tint Swe Latt, Than Than Aye, G. Vijayakumar, Manash Baruah, Fatema Jawad, A. G. Unnikrishnan, Subhankar Chowdhury, Md. Faruqe Pathan, Noel Somasundaram, Manilka Sumanathilaka, Abbas Raza, Silver K. Bahendeka, Ankia Coetzee, Sundeep Ruder, Kaushik Ramaiya, Roberta Lamptey, Charlotte Bavuma, Khalid Shaikh, Andrew Uloko, Sandeep Chaudhary, Abdurezak Ahmed Abdela, Zhanay Akanov, Joel Rodrìguez-Saldaña, Raquel Faradji, Armindo Tiago, Ahmed Reja, Leszek Czupryniak
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
Roy Rasalam, John Barlow, Mark Kennedy, Pat Phillips, Alan Wright
Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports
Nandu Thalange, Torben Biester, Thomas Danne
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
Marion L. Vetter, Kristina Johnsson, Elise Hardy, Hui Wang, Nayyar Iqbal
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report
Hae Jin Kim, Young Sik Kim, Chang Beom Lee, Moon-Gi Choi, Hyuk-Jae Chang, Soo Kyoung Kim, Jae Myung Yu, Tae Ho Kim, Ji Hyun Lee, Kyu Jeung Ahn, Kyoungmin Kim, Kwan Woo Lee
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Peter Gæde, Pierre Johansen, Christian Klyver Tikkanen, Richard Fulton Pollock, Barnaby Hunt, Samuel Joseph Paul Malkin
Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Peter Gæde, Pierre Johansen, Christian Klyver Tikkanen, Richard Fulton Pollock, Barnaby Hunt, Samuel Joseph Paul Malkin
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom
Meryl Brod, Amaury Basse, Marie Markert, Kathryn M. Pfeiffer
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy
Kali B. Turrin, Jennifer M. Trujillo
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy
Jakob Langer, Michael L. Wolden, Seiya Shimoda, Miki Sato, Eiichi Araki
Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients
Weinan Yu, Xiaoqing Wang, Yaojun Ni, De Huai, Hairong Hao, Qingjun Li, Ziyu Liu, Surong Wen, Liang Cheng, Wen Hu
Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor
Hitoshi Ishii, Yuki Suzaki, Yuko Miyata, Shingo Matsui
Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
Junling Fu, Tong Wang, Jieying Liu, Xiaojing Wang, Qian Zhang, Ming Li, Xinhua Xiao
Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
Li Zang, Yin Han, Lixian Chen, Daqing Hu, Hui Jin, Nailong Yang, Xiaoyun Shi, Linlang Liang, Mingming Liu, Hong Fan, Quanmin Li, Yiming Mu
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
John Doupis, Theodoros Alexandrides, Moses Elisaf, Andreas Melidonis, Stavros Bousboulas, Anastasia Thanopoulou, Emmanouil M. Pagkalos, Iakovos Avramidis, Angelos Pappas, Eleni Arvaniti, Eugenia Karamousouli, Bernd Voss, Nikolaos Tentolouris
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
Sandro Gentile, Felice Strollo, Ersilia Satta, Teresa Della Corte, Carmine Romano, Giuseppina Guarino
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
Yan Li, Ling Li, Yong De Peng, Guang Yao Song, Shan Dong Ye, Li Ying Du, Jia Ning Hou, Qiu He Ji
Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
Jee Hee Yoo, Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Yu Mi Kang, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
Clinical Outcomes of Transmetatarsal Amputation in Patients with Diabetic Foot Ulcers Treated without Revascularization
Shanshan Zhang, Shumin Wang, Lei Xu, Yang He, Jiali Xiang, Zhengyi Tang
Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study
Yuan Song, Xiaomei Zhang, Hengyan Zhang, Qingqing Yang, Shirong Zhang, Yadi Zhang, Yufei Chen, Yingchun Ji, Xiaolei Hu
Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis
Hongtao Lu, Bing Tang, Yanhua Zhou, Chenhong Xu, Pravesh Kumar Bundhun, Zhangui Tang, Hong Bao
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
W. David Strain, Phil McEwan, Heena Howitt, Simon Meadowcroft
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
Fumika Shigiyama, Shigenori Hiruma, Shinji Hisatake, Nobuyuki Shiraga, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro
Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
Björn Eliasson, Jan Ekelund, Rikard Amberntsson, Mervete Miftaraj, Ann-Marie Svensson
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM
Aya Osaki, Yoko Shimoda, Junichi Okada, Eijiro Yamada, Tsugumichi Saito, Yasuyo Nakajima, Atsushi Ozawa, Yawara Niijima, Shuichi Okada, Masanobu Yamada
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
Yuji Kawaguchi, Jun Sawa, Chie Hamai, Yasuro Kumeda
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation
Giuseppina Salzano, Stefano Passanisi, Corrado Mammì, Manuela Priolo, Letizia Pintomalli, Lucia Caminiti, Maria F. Messina, Giovanni B. Pajno, Fortunato Lombardo
Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.
Luigi Mario Castello, Marco Baldrighi, Francesco Gavelli, Gian Carlo Avanzi
Response to ‘Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.’
Hui-Chi Hsieh, Shin-Hwar Wu, Chun-Ching Chiu, Keng-Chu Ko